Evidence map›Paper›PMID 39717333›Full record

ArticleCureus2024

Gastrointestinal Stromal Tumor of the Rectum: Report of a Case With Long-Term Imatinib Treatment.

Madhumita Tripathi, Roli Purwar, Richie Sinha, Pooja Singh, Manoj Pandey

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Madhumita TripathiSurgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, IND.
Roli PurwarObstetrics and Gynaecology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, IND.
Richie SinhaSurgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, IND.
Pooja SinghOncological Research, Institute of Medical Sciences, Banaras Hindu University, Varanasi, IND.
Manoj PandeySurgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrointestinal stromal tumors (GIST) are rare in the rectum. These usually present with symptoms produced by compression of pelvic organs or bleeding. Surgery is the treatment of choice, however, at times the surgery can be mutilating and organ preservation may not be possible. In such cases imatinib can be used. We report a case of rectal GIST that presented with urinary obstruction and obstipation treated with long-term imatinib with very good response and relief of symptoms, which prompted the patient to refuse surgery and resulted in organ preservation.

Indexed as

gastrointestinal stromal tumor (gist)imatinib mesylateorgan preservationrectal tumortyrosine kinase receptor inhibitors

Identifiers

PMID39717333
PMCPMC11663722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.